1. Home
  2. RDY vs ENSG Comparison

RDY vs ENSG Comparison

Compare RDY & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$14.92

Market Cap

9.9B

Sector

Health Care

ML Signal

N/A

Logo The Ensign Group Inc.

ENSG

The Ensign Group Inc.

N/A

Current Price

$177.37

Market Cap

11.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RDY
ENSG
Founded
1984
1999
Country
India
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
11.0B
IPO Year
2001
2007

Fundamental Metrics

Financial Performance
Metric
RDY
ENSG
Price
$14.92
$177.37
Analyst Decision
Buy
Buy
Analyst Count
5
5
Target Price
$14.79
★ $225.80
AVG Volume (30 Days)
★ 2.4M
335.4K
Earning Date
10-23-2026
10-27-2026
Dividend Yield
★ 0.43%
0.15%
EPS Growth
N/A
★ 14.06
EPS
N/A
★ 5.11
Revenue
N/A
★ $5,057,841,000.00
Revenue This Year
$4.58
$16.82
Revenue Next Year
$11.95
$12.68
P/E Ratio
★ $18.67
$34.57
Revenue Growth
N/A
★ 18.72
52 Week Low
$11.36
$141.58
52 Week High
$15.67
$218.00

Technical Indicators

Market Signals
Indicator
RDY
ENSG
Relative Strength Index (RSI) 68.25 44.39
Support Level $12.91 $166.94
Resistance Level $15.08 $180.32
Average True Range (ATR) 0.26 4.24
MACD -0.04 -1.04
Stochastic Oscillator 78.74 5.54

Price Performance

Historical Comparison
RDY
ENSG

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About ENSG The Ensign Group Inc.

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

Share on Social Networks: